WallStSmart

Alcon AG (ALC)vsEnvista Holdings Corp (NVST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alcon AG generates 282% more annual revenue ($10.40B vs $2.72B). ALC leads profitability with a 9.4% profit margin vs 1.7%. ALC trades at a lower P/E of 37.5x. NVST earns a higher WallStSmart Score of 56/100 (C).

ALC

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 5.0Value: 7.3Quality: 7.3
Piotroski: 4/9

NVST

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 4.5Value: 3.0Quality: 7.0
Piotroski: 5/9Altman Z: 1.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALCSignificantly Overvalued (-489.8%)

Margin of Safety

-489.8%

Fair Value

$13.46

Current Price

$75.26

$61.80 premium

UndervaluedFair: $13.46Overvalued
NVSTSignificantly Overvalued (-131.0%)

Margin of Safety

-131.0%

Fair Value

$13.10

Current Price

$26.14

$13.04 premium

UndervaluedFair: $13.10Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALC2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

NVST3 strengths · Avg: 8.7/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
15.0%8/10

15.0% revenue growth

EPS GrowthGrowth
31.5%8/10

Earnings expanding 31.5% YoY

Areas to Watch

ALC4 concerns · Avg: 3.3/10
PEG RatioValuation
1.704/10

Expensive relative to growth rate

P/E RatioValuation
37.5x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
4.5%3/10

ROE of 4.5% — below average capital efficiency

EPS GrowthGrowth
-22.2%2/10

Earnings declined 22.2%

NVST4 concerns · Avg: 2.5/10
Return on EquityProfitability
1.6%3/10

ROE of 1.6% — below average capital efficiency

Profit MarginProfitability
1.7%3/10

1.7% margin — thin

P/E RatioValuation
93.0x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.472/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ALC

The strongest argument for ALC centers on Debt/Equity, Price/Book.

Bull Case : NVST

The strongest argument for NVST centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 15.0% demonstrates continued momentum.

Bear Case : ALC

The primary concerns for ALC are PEG Ratio, P/E Ratio, Return on Equity.

Bear Case : NVST

The primary concerns for NVST are Return on Equity, Profit Margin, P/E Ratio. A P/E of 93.0x leaves little room for execution misses. Thin 1.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

NVST carries more volatility with a beta of 0.95 — expect wider price swings.

NVST is growing revenue faster at 15.0% — sustainability is the question.

ALC generates stronger free cash flow (489M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NVST scores higher overall (56/100 vs 49/100) and 15.0% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alcon AG

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Visit Website →

Envista Holdings Corp

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Envista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally. The company is headquartered in Brea, California.

Visit Website →

Want to dig deeper into these stocks?